After a statewide legalization of recreational marijuana took effect in Massachusetts Thursday, some Harvard undergraduates said they think the new legislation will change the University’s “campus culture” for the better.
Recreational marijuana will be legal in Massachusetts starting Dec. 15, although the future of the drug on Harvard’s campus is uncertain as the University remains mum on changes to its drug and alcohol policy.
U.S. Surgeon General Vivek H. Murthy ’98 discussed the problems created by the current opiate drug abuse epidemic in the United States during a lecture at the Institute of Politics Monday evening. Moderated by HKS Professor Amitabh Chandra, the conversational lecture included discussion of public health policy and the future of health lawmaking under president-elect Donald Trump’s future administration.
Massachusetts narrowly approved the legalization of recreational marijuana on Tuesday night, and Harvard students are pretty excited about it.
Massachusetts voters opted to legalize marijuana and denied a proposed lift in the state's charter school cap that was contentious among state Democrats, along with handing Hillary Clinton an overwhelming majority in the state.
A group of Divinity School students and staff exchanged differing opinions on the Mass. referendum questions on charter school expansion and the legalization of Marijuana on Monday.
Sage Cannabis is one step closer to opening its proposed medical marijuana dispensary in Cambridge following a televised hearing in which city councillors questioned the company’s CEO regarding the safety of his proposed site.
In the post for 10 years, Ryan M. Travia is set to depart Harvard mid-March and take up an associate dean of students position at Babson College.
Harvard administrators and national experts said that while they are not surprised by the new policy at Dartmouth, they expect the changes to have little effect on Harvard College's alcohol policy.
The recent study examined the incidence of negative health effects in infants whose mothers used antiretrovirals and was designed to help doctors assemble the safest combination of HIV drugs by indicating which are associated with the least risk.